nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Topoisomerase Inhibitors—Epirubicin—bone cancer	0.187	0.519	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Doxorubicin—bone cancer	0.173	0.481	CiPCiCtD
Etoposide—GSTP1—bone cancer	0.0849	0.61	CbGaD
Etoposide—brain cancer—bone cancer	0.0552	0.213	CtDrD
Etoposide—prostate cancer—bone cancer	0.0429	0.166	CtDrD
Etoposide—muscle cancer—bone cancer	0.0372	0.144	CtDrD
Etoposide—germ cell cancer—bone cancer	0.0334	0.129	CtDrD
Etoposide—peripheral nervous system neoplasm—bone cancer	0.0308	0.119	CtDrD
Etoposide—lung cancer—bone cancer	0.03	0.116	CtDrD
Etoposide—sarcoma—bone cancer	0.0297	0.114	CtDrD
Etoposide—GSTT1—Carboplatin—bone cancer	0.0291	0.15	CbGbCtD
Etoposide—CYP3A4—bone cancer	0.0274	0.197	CbGaD
Etoposide—PTGS2—bone cancer	0.0269	0.193	CbGaD
Etoposide—GSTT1—Cisplatin—bone cancer	0.0249	0.128	CbGbCtD
Etoposide—GSTP1—Carboplatin—bone cancer	0.0182	0.0937	CbGbCtD
Etoposide—GSTP1—Cisplatin—bone cancer	0.0156	0.0801	CbGbCtD
Etoposide—ABCC6—Cisplatin—bone cancer	0.0143	0.0736	CbGbCtD
Etoposide—TOP2A—Epirubicin—bone cancer	0.0096	0.0494	CbGbCtD
Etoposide—ABCC6—Doxorubicin—bone cancer	0.00958	0.0493	CbGbCtD
Etoposide—ABCC10—Doxorubicin—bone cancer	0.00732	0.0377	CbGbCtD
Etoposide—ABCC10—Methotrexate—bone cancer	0.00709	0.0365	CbGbCtD
Etoposide—ABCC3—Cisplatin—bone cancer	0.00687	0.0354	CbGbCtD
Etoposide—ABCC1—Epirubicin—bone cancer	0.00532	0.0274	CbGbCtD
Etoposide—TOP2A—Doxorubicin—bone cancer	0.0051	0.0263	CbGbCtD
Etoposide—ABCC3—Doxorubicin—bone cancer	0.0046	0.0237	CbGbCtD
Etoposide—ABCC3—Methotrexate—bone cancer	0.00446	0.023	CbGbCtD
Etoposide—ABCC2—Carboplatin—bone cancer	0.00365	0.0188	CbGbCtD
Etoposide—ABCG2—Carboplatin—bone cancer	0.0033	0.017	CbGbCtD
Etoposide—ABCC2—Cisplatin—bone cancer	0.00312	0.0161	CbGbCtD
Etoposide—PTGS2—Cisplatin—bone cancer	0.00309	0.0159	CbGbCtD
Etoposide—ABCC1—Doxorubicin—bone cancer	0.00283	0.0146	CbGbCtD
Etoposide—ABCG2—Cisplatin—bone cancer	0.00282	0.0145	CbGbCtD
Etoposide—ABCC1—Methotrexate—bone cancer	0.00274	0.0141	CbGbCtD
Etoposide—ABCC2—Doxorubicin—bone cancer	0.00209	0.0108	CbGbCtD
Etoposide—ABCC2—Methotrexate—bone cancer	0.00203	0.0104	CbGbCtD
Etoposide—ABCG2—Doxorubicin—bone cancer	0.00189	0.00974	CbGbCtD
Etoposide—ABCG2—Methotrexate—bone cancer	0.00183	0.00943	CbGbCtD
Etoposide—ABCB1—Cisplatin—bone cancer	0.00102	0.00524	CbGbCtD
Etoposide—ABCB1—Doxorubicin—bone cancer	0.000682	0.00351	CbGbCtD
Etoposide—ABCB1—Methotrexate—bone cancer	0.000661	0.0034	CbGbCtD
Etoposide—CYP3A4—Doxorubicin—bone cancer	0.000409	0.0021	CbGbCtD
Etoposide—Podofilox—CYP3A4—bone cancer	0.000349	0.54	CrCbGaD
Etoposide—Teniposide—CYP3A4—bone cancer	0.000297	0.46	CrCbGaD
Etoposide—TOP2A—Doxorubicin—Epirubicin—bone cancer	9.04e-05	0.173	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Epirubicin—bone cancer	9.04e-05	0.173	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Epirubicin—bone cancer	9.04e-05	0.173	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Doxorubicin—bone cancer	8.37e-05	0.16	CbGdCrCtD
Etoposide—TOP2A—Epirubicin—Doxorubicin—bone cancer	8.37e-05	0.16	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Doxorubicin—bone cancer	8.37e-05	0.16	CbGdCrCtD
Etoposide—Cardiac failure congestive—Epirubicin—bone cancer	5.1e-05	0.00164	CcSEcCtD
Etoposide—Ill-defined disorder—Cisplatin—bone cancer	5.04e-05	0.00162	CcSEcCtD
Etoposide—Anaemia—Cisplatin—bone cancer	5.02e-05	0.00161	CcSEcCtD
Etoposide—Phlebitis—Doxorubicin—bone cancer	4.97e-05	0.0016	CcSEcCtD
Etoposide—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	4.92e-05	0.00158	CcSEcCtD
Etoposide—Malaise—Cisplatin—bone cancer	4.89e-05	0.00157	CcSEcCtD
Etoposide—Leukopenia—Cisplatin—bone cancer	4.86e-05	0.00156	CcSEcCtD
Etoposide—Anaphylactoid reaction—Epirubicin—bone cancer	4.78e-05	0.00153	CcSEcCtD
Etoposide—Cardiac failure—Epirubicin—bone cancer	4.74e-05	0.00152	CcSEcCtD
Etoposide—Cardiac failure congestive—Doxorubicin—bone cancer	4.72e-05	0.00152	CcSEcCtD
Etoposide—Convulsion—Cisplatin—bone cancer	4.7e-05	0.00151	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	4.59e-05	0.00147	CcSEcCtD
Etoposide—Discomfort—Cisplatin—bone cancer	4.56e-05	0.00147	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Methotrexate—bone cancer	4.45e-05	0.00143	CcSEcCtD
Etoposide—Anaphylactic shock—Cisplatin—bone cancer	4.43e-05	0.00142	CcSEcCtD
Etoposide—Anaphylactoid reaction—Doxorubicin—bone cancer	4.42e-05	0.00142	CcSEcCtD
Etoposide—Cardiac arrest—Epirubicin—bone cancer	4.4e-05	0.00141	CcSEcCtD
Etoposide—Infection—Cisplatin—bone cancer	4.4e-05	0.00141	CcSEcCtD
Etoposide—Cardiac failure—Doxorubicin—bone cancer	4.39e-05	0.00141	CcSEcCtD
Etoposide—Thrombocytopenia—Cisplatin—bone cancer	4.34e-05	0.00139	CcSEcCtD
Etoposide—Tachycardia—Cisplatin—bone cancer	4.32e-05	0.00139	CcSEcCtD
Etoposide—Skin disorder—Cisplatin—bone cancer	4.3e-05	0.00138	CcSEcCtD
Etoposide—Hyperhidrosis—Cisplatin—bone cancer	4.28e-05	0.00137	CcSEcCtD
Etoposide—Anorexia—Cisplatin—bone cancer	4.22e-05	0.00136	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Epirubicin—bone cancer	4.17e-05	0.00134	CcSEcCtD
Etoposide—Hypotension—Cisplatin—bone cancer	4.14e-05	0.00133	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Epirubicin—bone cancer	4.08e-05	0.00131	CcSEcCtD
Etoposide—Cardiac arrest—Doxorubicin—bone cancer	4.07e-05	0.00131	CcSEcCtD
Etoposide—Pancytopenia—Methotrexate—bone cancer	4.06e-05	0.0013	CcSEcCtD
Etoposide—Dysphagia—Epirubicin—bone cancer	4e-05	0.00128	CcSEcCtD
Etoposide—Neutropenia—Methotrexate—bone cancer	4e-05	0.00128	CcSEcCtD
Etoposide—Paraesthesia—Cisplatin—bone cancer	3.98e-05	0.00128	CcSEcCtD
Etoposide—Dyspnoea—Cisplatin—bone cancer	3.95e-05	0.00127	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Doxorubicin—bone cancer	3.86e-05	0.00124	CcSEcCtD
Etoposide—Decreased appetite—Cisplatin—bone cancer	3.85e-05	0.00124	CcSEcCtD
Etoposide—Pneumonia—Methotrexate—bone cancer	3.83e-05	0.00123	CcSEcCtD
Etoposide—Gastrointestinal disorder—Cisplatin—bone cancer	3.82e-05	0.00123	CcSEcCtD
Etoposide—Infestation—Methotrexate—bone cancer	3.81e-05	0.00122	CcSEcCtD
Etoposide—Infestation NOS—Methotrexate—bone cancer	3.81e-05	0.00122	CcSEcCtD
Etoposide—Pancytopenia—Epirubicin—bone cancer	3.8e-05	0.00122	CcSEcCtD
Etoposide—Pain—Cisplatin—bone cancer	3.79e-05	0.00122	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Methotrexate—bone cancer	3.78e-05	0.00121	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Doxorubicin—bone cancer	3.78e-05	0.00121	CcSEcCtD
Etoposide—Renal failure—Methotrexate—bone cancer	3.75e-05	0.0012	CcSEcCtD
Etoposide—Neutropenia—Epirubicin—bone cancer	3.74e-05	0.0012	CcSEcCtD
Etoposide—Stomatitis—Methotrexate—bone cancer	3.71e-05	0.00119	CcSEcCtD
Etoposide—Dysphagia—Doxorubicin—bone cancer	3.7e-05	0.00119	CcSEcCtD
Etoposide—Feeling abnormal—Cisplatin—bone cancer	3.65e-05	0.00117	CcSEcCtD
Etoposide—Hepatobiliary disease—Methotrexate—bone cancer	3.6e-05	0.00116	CcSEcCtD
Etoposide—Pneumonia—Epirubicin—bone cancer	3.59e-05	0.00115	CcSEcCtD
Etoposide—Infestation NOS—Epirubicin—bone cancer	3.57e-05	0.00114	CcSEcCtD
Etoposide—Infestation—Epirubicin—bone cancer	3.57e-05	0.00114	CcSEcCtD
Etoposide—Agranulocytosis—Methotrexate—bone cancer	3.56e-05	0.00114	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Epirubicin—bone cancer	3.54e-05	0.00113	CcSEcCtD
Etoposide—Pancytopenia—Doxorubicin—bone cancer	3.51e-05	0.00113	CcSEcCtD
Etoposide—Renal failure—Epirubicin—bone cancer	3.51e-05	0.00113	CcSEcCtD
Etoposide—Body temperature increased—Cisplatin—bone cancer	3.5e-05	0.00112	CcSEcCtD
Etoposide—Neuropathy peripheral—Epirubicin—bone cancer	3.5e-05	0.00112	CcSEcCtD
Etoposide—Stomatitis—Epirubicin—bone cancer	3.48e-05	0.00112	CcSEcCtD
Etoposide—Jaundice—Epirubicin—bone cancer	3.48e-05	0.00112	CcSEcCtD
Etoposide—Neutropenia—Doxorubicin—bone cancer	3.46e-05	0.00111	CcSEcCtD
Etoposide—Urinary tract disorder—Methotrexate—bone cancer	3.38e-05	0.00108	CcSEcCtD
Etoposide—Hepatobiliary disease—Epirubicin—bone cancer	3.37e-05	0.00108	CcSEcCtD
Etoposide—Urethral disorder—Methotrexate—bone cancer	3.35e-05	0.00108	CcSEcCtD
Etoposide—Agranulocytosis—Epirubicin—bone cancer	3.33e-05	0.00107	CcSEcCtD
Etoposide—Pneumonia—Doxorubicin—bone cancer	3.32e-05	0.00107	CcSEcCtD
Etoposide—Infestation—Doxorubicin—bone cancer	3.3e-05	0.00106	CcSEcCtD
Etoposide—Infestation NOS—Doxorubicin—bone cancer	3.3e-05	0.00106	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Doxorubicin—bone cancer	3.27e-05	0.00105	CcSEcCtD
Etoposide—Hypersensitivity—Cisplatin—bone cancer	3.26e-05	0.00105	CcSEcCtD
Etoposide—Renal failure—Doxorubicin—bone cancer	3.24e-05	0.00104	CcSEcCtD
Etoposide—Erythema multiforme—Methotrexate—bone cancer	3.23e-05	0.00104	CcSEcCtD
Etoposide—Neuropathy peripheral—Doxorubicin—bone cancer	3.23e-05	0.00104	CcSEcCtD
Etoposide—Jaundice—Doxorubicin—bone cancer	3.22e-05	0.00103	CcSEcCtD
Etoposide—Stomatitis—Doxorubicin—bone cancer	3.22e-05	0.00103	CcSEcCtD
Etoposide—Eye disorder—Methotrexate—bone cancer	3.2e-05	0.00103	CcSEcCtD
Etoposide—Hypoaesthesia—Epirubicin—bone cancer	3.19e-05	0.00102	CcSEcCtD
Etoposide—Asthenia—Cisplatin—bone cancer	3.18e-05	0.00102	CcSEcCtD
Etoposide—Cardiac disorder—Methotrexate—bone cancer	3.17e-05	0.00102	CcSEcCtD
Etoposide—Urinary tract disorder—Epirubicin—bone cancer	3.16e-05	0.00101	CcSEcCtD
Etoposide—Urethral disorder—Epirubicin—bone cancer	3.14e-05	0.00101	CcSEcCtD
Etoposide—Hepatobiliary disease—Doxorubicin—bone cancer	3.12e-05	0.001	CcSEcCtD
Etoposide—Angiopathy—Methotrexate—bone cancer	3.1e-05	0.000996	CcSEcCtD
Etoposide—Immune system disorder—Methotrexate—bone cancer	3.09e-05	0.000992	CcSEcCtD
Etoposide—Mediastinal disorder—Methotrexate—bone cancer	3.08e-05	0.00099	CcSEcCtD
Etoposide—Agranulocytosis—Doxorubicin—bone cancer	3.08e-05	0.000988	CcSEcCtD
Etoposide—Chills—Methotrexate—bone cancer	3.07e-05	0.000985	CcSEcCtD
Etoposide—Diarrhoea—Cisplatin—bone cancer	3.03e-05	0.000973	CcSEcCtD
Etoposide—Erythema multiforme—Epirubicin—bone cancer	3.03e-05	0.000972	CcSEcCtD
Etoposide—Alopecia—Methotrexate—bone cancer	3.02e-05	0.00097	CcSEcCtD
Etoposide—Eye disorder—Epirubicin—bone cancer	2.99e-05	0.00096	CcSEcCtD
Etoposide—Cardiac disorder—Epirubicin—bone cancer	2.97e-05	0.000954	CcSEcCtD
Etoposide—Flushing—Epirubicin—bone cancer	2.97e-05	0.000954	CcSEcCtD
Etoposide—Hypoaesthesia—Doxorubicin—bone cancer	2.95e-05	0.000946	CcSEcCtD
Etoposide—Urinary tract disorder—Doxorubicin—bone cancer	2.93e-05	0.000939	CcSEcCtD
Etoposide—Dysgeusia—Methotrexate—bone cancer	2.92e-05	0.000936	CcSEcCtD
Etoposide—Angiopathy—Epirubicin—bone cancer	2.9e-05	0.000932	CcSEcCtD
Etoposide—Urethral disorder—Doxorubicin—bone cancer	2.9e-05	0.000932	CcSEcCtD
Etoposide—Immune system disorder—Epirubicin—bone cancer	2.89e-05	0.000928	CcSEcCtD
Etoposide—Mediastinal disorder—Epirubicin—bone cancer	2.89e-05	0.000926	CcSEcCtD
Etoposide—Back pain—Methotrexate—bone cancer	2.88e-05	0.000925	CcSEcCtD
Etoposide—Chills—Epirubicin—bone cancer	2.87e-05	0.000922	CcSEcCtD
Etoposide—Alopecia—Epirubicin—bone cancer	2.83e-05	0.000908	CcSEcCtD
Etoposide—Vomiting—Cisplatin—bone cancer	2.82e-05	0.000904	CcSEcCtD
Etoposide—Erythema multiforme—Doxorubicin—bone cancer	2.8e-05	0.000899	CcSEcCtD
Etoposide—Rash—Cisplatin—bone cancer	2.79e-05	0.000896	CcSEcCtD
Etoposide—Dermatitis—Cisplatin—bone cancer	2.79e-05	0.000896	CcSEcCtD
Etoposide—Eye disorder—Doxorubicin—bone cancer	2.77e-05	0.000889	CcSEcCtD
Etoposide—Ill-defined disorder—Methotrexate—bone cancer	2.76e-05	0.000887	CcSEcCtD
Etoposide—Anaemia—Methotrexate—bone cancer	2.75e-05	0.000884	CcSEcCtD
Etoposide—Flushing—Doxorubicin—bone cancer	2.75e-05	0.000882	CcSEcCtD
Etoposide—Cardiac disorder—Doxorubicin—bone cancer	2.75e-05	0.000882	CcSEcCtD
Etoposide—Dysgeusia—Epirubicin—bone cancer	2.73e-05	0.000876	CcSEcCtD
Etoposide—Back pain—Epirubicin—bone cancer	2.7e-05	0.000865	CcSEcCtD
Etoposide—Angiopathy—Doxorubicin—bone cancer	2.69e-05	0.000863	CcSEcCtD
Etoposide—Malaise—Methotrexate—bone cancer	2.69e-05	0.000862	CcSEcCtD
Etoposide—Muscle spasms—Epirubicin—bone cancer	2.68e-05	0.00086	CcSEcCtD
Etoposide—Immune system disorder—Doxorubicin—bone cancer	2.68e-05	0.000859	CcSEcCtD
Etoposide—Vertigo—Methotrexate—bone cancer	2.68e-05	0.000859	CcSEcCtD
Etoposide—Mediastinal disorder—Doxorubicin—bone cancer	2.67e-05	0.000857	CcSEcCtD
Etoposide—Leukopenia—Methotrexate—bone cancer	2.67e-05	0.000856	CcSEcCtD
Etoposide—Chills—Doxorubicin—bone cancer	2.66e-05	0.000853	CcSEcCtD
Etoposide—Nausea—Cisplatin—bone cancer	2.63e-05	0.000844	CcSEcCtD
Etoposide—Alopecia—Doxorubicin—bone cancer	2.62e-05	0.00084	CcSEcCtD
Etoposide—Cough—Methotrexate—bone cancer	2.6e-05	0.000834	CcSEcCtD
Etoposide—Ill-defined disorder—Epirubicin—bone cancer	2.59e-05	0.00083	CcSEcCtD
Etoposide—Convulsion—Methotrexate—bone cancer	2.58e-05	0.000828	CcSEcCtD
Etoposide—Anaemia—Epirubicin—bone cancer	2.58e-05	0.000827	CcSEcCtD
Etoposide—Chest pain—Methotrexate—bone cancer	2.54e-05	0.000814	CcSEcCtD
Etoposide—Dysgeusia—Doxorubicin—bone cancer	2.53e-05	0.000811	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	2.52e-05	0.000808	CcSEcCtD
Etoposide—Malaise—Epirubicin—bone cancer	2.51e-05	0.000807	CcSEcCtD
Etoposide—TOP2A—Cell Cycle—RFC1—bone cancer	2.51e-05	0.00163	CbGpPWpGaD
Etoposide—Discomfort—Methotrexate—bone cancer	2.5e-05	0.000804	CcSEcCtD
Etoposide—Vertigo—Epirubicin—bone cancer	2.5e-05	0.000804	CcSEcCtD
Etoposide—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	2.5e-05	0.00163	CbGpPWpGaD
Etoposide—Leukopenia—Epirubicin—bone cancer	2.49e-05	0.000801	CcSEcCtD
Etoposide—Back pain—Doxorubicin—bone cancer	2.49e-05	0.000801	CcSEcCtD
Etoposide—TOP2A—Mitotic G1-G1/S phases—CDK4—bone cancer	2.49e-05	0.00162	CbGpPWpGaD
Etoposide—Muscle spasms—Doxorubicin—bone cancer	2.48e-05	0.000796	CcSEcCtD
Etoposide—Confusional state—Methotrexate—bone cancer	2.45e-05	0.000787	CcSEcCtD
Etoposide—Loss of consciousness—Epirubicin—bone cancer	2.45e-05	0.000786	CcSEcCtD
Etoposide—Cough—Epirubicin—bone cancer	2.43e-05	0.000781	CcSEcCtD
Etoposide—Anaphylactic shock—Methotrexate—bone cancer	2.43e-05	0.00078	CcSEcCtD
Etoposide—Convulsion—Epirubicin—bone cancer	2.41e-05	0.000775	CcSEcCtD
Etoposide—Infection—Methotrexate—bone cancer	2.41e-05	0.000775	CcSEcCtD
Etoposide—Hypertension—Epirubicin—bone cancer	2.41e-05	0.000772	CcSEcCtD
Etoposide—Ill-defined disorder—Doxorubicin—bone cancer	2.39e-05	0.000768	CcSEcCtD
Etoposide—Anaemia—Doxorubicin—bone cancer	2.38e-05	0.000765	CcSEcCtD
Etoposide—Thrombocytopenia—Methotrexate—bone cancer	2.38e-05	0.000764	CcSEcCtD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—RB1—bone cancer	2.38e-05	0.00155	CbGpPWpGaD
Etoposide—UGT1A1—Biological oxidations—CYP3A4—bone cancer	2.37e-05	0.00155	CbGpPWpGaD
Etoposide—Chest pain—Epirubicin—bone cancer	2.37e-05	0.000762	CcSEcCtD
Etoposide—Skin disorder—Methotrexate—bone cancer	2.36e-05	0.000758	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	2.36e-05	0.000756	CcSEcCtD
Etoposide—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	2.35e-05	0.00153	CbGpPWpGaD
Etoposide—Hyperhidrosis—Methotrexate—bone cancer	2.35e-05	0.000754	CcSEcCtD
Etoposide—GSTP1—Metabolism—NT5C3A—bone cancer	2.35e-05	0.00153	CbGpPWpGaD
Etoposide—Discomfort—Epirubicin—bone cancer	2.34e-05	0.000752	CcSEcCtD
Etoposide—UGT1A1—Metapathway biotransformation—CYP3A4—bone cancer	2.34e-05	0.00153	CbGpPWpGaD
Etoposide—Malaise—Doxorubicin—bone cancer	2.33e-05	0.000746	CcSEcCtD
Etoposide—Vertigo—Doxorubicin—bone cancer	2.32e-05	0.000744	CcSEcCtD
Etoposide—Anorexia—Methotrexate—bone cancer	2.32e-05	0.000744	CcSEcCtD
Etoposide—UGT1A1—NRF2 pathway—GSTP1—bone cancer	2.32e-05	0.00151	CbGpPWpGaD
Etoposide—UGT1A1—NRF2 pathway—TGFBR2—bone cancer	2.32e-05	0.00151	CbGpPWpGaD
Etoposide—Leukopenia—Doxorubicin—bone cancer	2.31e-05	0.000741	CcSEcCtD
Etoposide—PTGS1—Arachidonic acid metabolism—PTGS2—bone cancer	2.3e-05	0.0015	CbGpPWpGaD
Etoposide—Confusional state—Epirubicin—bone cancer	2.29e-05	0.000736	CcSEcCtD
Etoposide—Anaphylactic shock—Epirubicin—bone cancer	2.27e-05	0.00073	CcSEcCtD
Etoposide—Hypotension—Methotrexate—bone cancer	2.27e-05	0.000729	CcSEcCtD
Etoposide—Loss of consciousness—Doxorubicin—bone cancer	2.27e-05	0.000727	CcSEcCtD
Etoposide—Infection—Epirubicin—bone cancer	2.26e-05	0.000725	CcSEcCtD
Etoposide—ABCC2—NRF2 pathway—TGFBR2—bone cancer	2.26e-05	0.00147	CbGpPWpGaD
Etoposide—ABCC2—NRF2 pathway—GSTP1—bone cancer	2.26e-05	0.00147	CbGpPWpGaD
Etoposide—Cough—Doxorubicin—bone cancer	2.25e-05	0.000722	CcSEcCtD
Etoposide—ABCC3—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.24e-05	0.00146	CbGpPWpGaD
Etoposide—Convulsion—Doxorubicin—bone cancer	2.23e-05	0.000717	CcSEcCtD
Etoposide—Thrombocytopenia—Epirubicin—bone cancer	2.23e-05	0.000715	CcSEcCtD
Etoposide—Hypertension—Doxorubicin—bone cancer	2.23e-05	0.000715	CcSEcCtD
Etoposide—Tachycardia—Epirubicin—bone cancer	2.22e-05	0.000713	CcSEcCtD
Etoposide—Skin disorder—Epirubicin—bone cancer	2.21e-05	0.000709	CcSEcCtD
Etoposide—Hyperhidrosis—Epirubicin—bone cancer	2.2e-05	0.000706	CcSEcCtD
Etoposide—Chest pain—Doxorubicin—bone cancer	2.2e-05	0.000705	CcSEcCtD
Etoposide—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	2.19e-05	0.00143	CbGpPWpGaD
Etoposide—Paraesthesia—Methotrexate—bone cancer	2.18e-05	0.000701	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	2.18e-05	0.0007	CcSEcCtD
Etoposide—Discomfort—Doxorubicin—bone cancer	2.17e-05	0.000696	CcSEcCtD
Etoposide—Anorexia—Epirubicin—bone cancer	2.17e-05	0.000696	CcSEcCtD
Etoposide—Dyspnoea—Methotrexate—bone cancer	2.17e-05	0.000696	CcSEcCtD
Etoposide—TOP2A—Mitotic G1-G1/S phases—RB1—bone cancer	2.16e-05	0.00141	CbGpPWpGaD
Etoposide—Somnolence—Methotrexate—bone cancer	2.16e-05	0.000694	CcSEcCtD
Etoposide—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	2.14e-05	0.0014	CbGpPWpGaD
Etoposide—Hypotension—Epirubicin—bone cancer	2.13e-05	0.000682	CcSEcCtD
Etoposide—Confusional state—Doxorubicin—bone cancer	2.12e-05	0.000681	CcSEcCtD
Etoposide—Decreased appetite—Methotrexate—bone cancer	2.11e-05	0.000678	CcSEcCtD
Etoposide—Anaphylactic shock—Doxorubicin—bone cancer	2.1e-05	0.000676	CcSEcCtD
Etoposide—Gastrointestinal disorder—Methotrexate—bone cancer	2.1e-05	0.000674	CcSEcCtD
Etoposide—Fatigue—Methotrexate—bone cancer	2.1e-05	0.000673	CcSEcCtD
Etoposide—Infection—Doxorubicin—bone cancer	2.09e-05	0.000671	CcSEcCtD
Etoposide—GSTP1—Cellular responses to stress—CDK4—bone cancer	2.08e-05	0.00136	CbGpPWpGaD
Etoposide—Pain—Methotrexate—bone cancer	2.08e-05	0.000667	CcSEcCtD
Etoposide—Thrombocytopenia—Doxorubicin—bone cancer	2.06e-05	0.000661	CcSEcCtD
Etoposide—Tachycardia—Doxorubicin—bone cancer	2.05e-05	0.000659	CcSEcCtD
Etoposide—Skin disorder—Doxorubicin—bone cancer	2.04e-05	0.000656	CcSEcCtD
Etoposide—Paraesthesia—Epirubicin—bone cancer	2.04e-05	0.000656	CcSEcCtD
Etoposide—Hyperhidrosis—Doxorubicin—bone cancer	2.03e-05	0.000653	CcSEcCtD
Etoposide—UGT1A1—Biological oxidations—GSTP1—bone cancer	2.03e-05	0.00132	CbGpPWpGaD
Etoposide—Dyspnoea—Epirubicin—bone cancer	2.03e-05	0.000651	CcSEcCtD
Etoposide—Somnolence—Epirubicin—bone cancer	2.02e-05	0.000649	CcSEcCtD
Etoposide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	2.02e-05	0.00132	CbGpPWpGaD
Etoposide—Anorexia—Doxorubicin—bone cancer	2.01e-05	0.000644	CcSEcCtD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	2e-05	0.00131	CbGpPWpGaD
Etoposide—UGT1A1—Metapathway biotransformation—GSTP1—bone cancer	2e-05	0.00131	CbGpPWpGaD
Etoposide—Feeling abnormal—Methotrexate—bone cancer	2e-05	0.000643	CcSEcCtD
Etoposide—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	1.99e-05	0.0013	CbGpPWpGaD
Etoposide—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	1.99e-05	0.0013	CbGpPWpGaD
Etoposide—Gastrointestinal pain—Methotrexate—bone cancer	1.99e-05	0.000638	CcSEcCtD
Etoposide—Decreased appetite—Epirubicin—bone cancer	1.98e-05	0.000635	CcSEcCtD
Etoposide—Hypotension—Doxorubicin—bone cancer	1.97e-05	0.000631	CcSEcCtD
Etoposide—Gastrointestinal disorder—Epirubicin—bone cancer	1.96e-05	0.00063	CcSEcCtD
Etoposide—Fatigue—Epirubicin—bone cancer	1.96e-05	0.000629	CcSEcCtD
Etoposide—Pain—Epirubicin—bone cancer	1.94e-05	0.000624	CcSEcCtD
Etoposide—Constipation—Epirubicin—bone cancer	1.94e-05	0.000624	CcSEcCtD
Etoposide—PTGS1—Biological oxidations—CYP3A4—bone cancer	1.94e-05	0.00126	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.93e-05	0.00126	CbGpPWpGaD
Etoposide—Urticaria—Methotrexate—bone cancer	1.93e-05	0.00062	CcSEcCtD
Etoposide—Abdominal pain—Methotrexate—bone cancer	1.92e-05	0.000617	CcSEcCtD
Etoposide—Body temperature increased—Methotrexate—bone cancer	1.92e-05	0.000617	CcSEcCtD
Etoposide—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	1.91e-05	0.00124	CbGpPWpGaD
Etoposide—Paraesthesia—Doxorubicin—bone cancer	1.89e-05	0.000607	CcSEcCtD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	1.89e-05	0.00123	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—ENO2—bone cancer	1.88e-05	0.00122	CbGpPWpGaD
Etoposide—Dyspnoea—Doxorubicin—bone cancer	1.88e-05	0.000602	CcSEcCtD
Etoposide—Feeling abnormal—Epirubicin—bone cancer	1.87e-05	0.000602	CcSEcCtD
Etoposide—Somnolence—Doxorubicin—bone cancer	1.87e-05	0.000601	CcSEcCtD
Etoposide—Gastrointestinal pain—Epirubicin—bone cancer	1.86e-05	0.000597	CcSEcCtD
Etoposide—Decreased appetite—Doxorubicin—bone cancer	1.83e-05	0.000587	CcSEcCtD
Etoposide—Gastrointestinal disorder—Doxorubicin—bone cancer	1.82e-05	0.000583	CcSEcCtD
Etoposide—Fatigue—Doxorubicin—bone cancer	1.81e-05	0.000582	CcSEcCtD
Etoposide—TOP2A—Circadian rythm related genes—CDK4—bone cancer	1.81e-05	0.00118	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—RB1—bone cancer	1.81e-05	0.00118	CbGpPWpGaD
Etoposide—Urticaria—Epirubicin—bone cancer	1.81e-05	0.00058	CcSEcCtD
Etoposide—Constipation—Doxorubicin—bone cancer	1.8e-05	0.000578	CcSEcCtD
Etoposide—Pain—Doxorubicin—bone cancer	1.8e-05	0.000578	CcSEcCtD
Etoposide—Abdominal pain—Epirubicin—bone cancer	1.8e-05	0.000577	CcSEcCtD
Etoposide—Body temperature increased—Epirubicin—bone cancer	1.8e-05	0.000577	CcSEcCtD
Etoposide—Hypersensitivity—Methotrexate—bone cancer	1.79e-05	0.000575	CcSEcCtD
Etoposide—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.78e-05	0.00116	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.76e-05	0.00114	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—NDUFA12—bone cancer	1.75e-05	0.00114	CbGpPWpGaD
Etoposide—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	1.75e-05	0.00114	CbGpPWpGaD
Etoposide—Asthenia—Methotrexate—bone cancer	1.74e-05	0.00056	CcSEcCtD
Etoposide—GSTT1—Metabolism—DHFR—bone cancer	1.74e-05	0.00114	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—DHFR—bone cancer	1.74e-05	0.00113	CbGpPWpGaD
Etoposide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	1.74e-05	0.00113	CbGpPWpGaD
Etoposide—Feeling abnormal—Doxorubicin—bone cancer	1.73e-05	0.000557	CcSEcCtD
Etoposide—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	1.73e-05	0.00113	CbGpPWpGaD
Etoposide—Gastrointestinal pain—Doxorubicin—bone cancer	1.72e-05	0.000552	CcSEcCtD
Etoposide—Pruritus—Methotrexate—bone cancer	1.72e-05	0.000552	CcSEcCtD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	1.7e-05	0.00111	CbGpPWpGaD
Etoposide—Hypersensitivity—Epirubicin—bone cancer	1.68e-05	0.000538	CcSEcCtD
Etoposide—Urticaria—Doxorubicin—bone cancer	1.67e-05	0.000537	CcSEcCtD
Etoposide—Body temperature increased—Doxorubicin—bone cancer	1.66e-05	0.000534	CcSEcCtD
Etoposide—Abdominal pain—Doxorubicin—bone cancer	1.66e-05	0.000534	CcSEcCtD
Etoposide—Diarrhoea—Methotrexate—bone cancer	1.66e-05	0.000534	CcSEcCtD
Etoposide—PTGS1—Biological oxidations—GSTP1—bone cancer	1.66e-05	0.00108	CbGpPWpGaD
Etoposide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—bone cancer	1.65e-05	0.00107	CbGpPWpGaD
Etoposide—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	1.64e-05	0.00107	CbGpPWpGaD
Etoposide—Asthenia—Epirubicin—bone cancer	1.63e-05	0.000524	CcSEcCtD
Etoposide—GSTT1—Metabolism—GNA11—bone cancer	1.63e-05	0.00106	CbGpPWpGaD
Etoposide—Pruritus—Epirubicin—bone cancer	1.61e-05	0.000517	CcSEcCtD
Etoposide—Dizziness—Methotrexate—bone cancer	1.61e-05	0.000516	CcSEcCtD
Etoposide—PTGS2—C-MYB transcription factor network—KIT—bone cancer	1.59e-05	0.00104	CbGpPWpGaD
Etoposide—Diarrhoea—Epirubicin—bone cancer	1.56e-05	0.0005	CcSEcCtD
Etoposide—TOP2A—Cell Cycle—DHFR—bone cancer	1.55e-05	0.00101	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	1.55e-05	0.00101	CbGpPWpGaD
Etoposide—Hypersensitivity—Doxorubicin—bone cancer	1.55e-05	0.000498	CcSEcCtD
Etoposide—Vomiting—Methotrexate—bone cancer	1.55e-05	0.000496	CcSEcCtD
Etoposide—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.54e-05	0.00101	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—MDM2—bone cancer	1.54e-05	0.00101	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.53e-05	0.000999	CbGpPWpGaD
Etoposide—Rash—Methotrexate—bone cancer	1.53e-05	0.000492	CcSEcCtD
Etoposide—Dermatitis—Methotrexate—bone cancer	1.53e-05	0.000491	CcSEcCtD
Etoposide—Headache—Methotrexate—bone cancer	1.52e-05	0.000489	CcSEcCtD
Etoposide—ABCC1—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.52e-05	0.000988	CbGpPWpGaD
Etoposide—Asthenia—Doxorubicin—bone cancer	1.51e-05	0.000485	CcSEcCtD
Etoposide—TOP2A—Retinoblastoma (RB) in Cancer—TP53—bone cancer	1.51e-05	0.000981	CbGpPWpGaD
Etoposide—Dizziness—Epirubicin—bone cancer	1.5e-05	0.000483	CcSEcCtD
Etoposide—Pruritus—Doxorubicin—bone cancer	1.49e-05	0.000478	CcSEcCtD
Etoposide—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	1.49e-05	0.00097	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—CYP3A4—bone cancer	1.48e-05	0.000962	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—PTGS2—bone cancer	1.47e-05	0.000955	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—NT5C3A—bone cancer	1.45e-05	0.000946	CbGpPWpGaD
Etoposide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	1.45e-05	0.000944	CbGpPWpGaD
Etoposide—CYP2E1—Biological oxidations—CYP3A4—bone cancer	1.45e-05	0.000943	CbGpPWpGaD
Etoposide—Vomiting—Epirubicin—bone cancer	1.45e-05	0.000464	CcSEcCtD
Etoposide—Nausea—Methotrexate—bone cancer	1.44e-05	0.000463	CcSEcCtD
Etoposide—CYP3A5—Biological oxidations—CYP3A4—bone cancer	1.44e-05	0.000941	CbGpPWpGaD
Etoposide—Diarrhoea—Doxorubicin—bone cancer	1.44e-05	0.000462	CcSEcCtD
Etoposide—Rash—Epirubicin—bone cancer	1.43e-05	0.00046	CcSEcCtD
Etoposide—Dermatitis—Epirubicin—bone cancer	1.43e-05	0.00046	CcSEcCtD
Etoposide—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	1.43e-05	0.00093	CbGpPWpGaD
Etoposide—Headache—Epirubicin—bone cancer	1.42e-05	0.000457	CcSEcCtD
Etoposide—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	1.42e-05	0.000928	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—NDUFA12—bone cancer	1.42e-05	0.000928	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	1.42e-05	0.000926	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	1.41e-05	0.000921	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.4e-05	0.000911	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	1.39e-05	0.000908	CbGpPWpGaD
Etoposide—Dizziness—Doxorubicin—bone cancer	1.39e-05	0.000447	CcSEcCtD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	1.39e-05	0.000903	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—NDUFA12—bone cancer	1.37e-05	0.000894	CbGpPWpGaD
Etoposide—Nausea—Epirubicin—bone cancer	1.35e-05	0.000434	CcSEcCtD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.35e-05	0.000878	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	1.35e-05	0.000877	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—JUN—bone cancer	1.34e-05	0.000874	CbGpPWpGaD
Etoposide—Vomiting—Doxorubicin—bone cancer	1.34e-05	0.00043	CcSEcCtD
Etoposide—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.33e-05	0.000869	CbGpPWpGaD
Etoposide—Rash—Doxorubicin—bone cancer	1.33e-05	0.000426	CcSEcCtD
Etoposide—Dermatitis—Doxorubicin—bone cancer	1.33e-05	0.000426	CcSEcCtD
Etoposide—Headache—Doxorubicin—bone cancer	1.32e-05	0.000423	CcSEcCtD
Etoposide—TOP2A—Cell Cycle—CHEK2—bone cancer	1.3e-05	0.000846	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—CDK4—bone cancer	1.29e-05	0.000839	CbGpPWpGaD
Etoposide—CYP1A2—Phase II conjugation—GSTP1—bone cancer	1.27e-05	0.000828	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—GSTP1—bone cancer	1.26e-05	0.000823	CbGpPWpGaD
Etoposide—CYP2C8—Biological oxidations—CYP3A4—bone cancer	1.25e-05	0.000815	CbGpPWpGaD
Etoposide—Nausea—Doxorubicin—bone cancer	1.25e-05	0.000401	CcSEcCtD
Etoposide—CYP2E1—Biological oxidations—GSTP1—bone cancer	1.24e-05	0.000806	CbGpPWpGaD
Etoposide—CYP3A5—Biological oxidations—GSTP1—bone cancer	1.23e-05	0.000805	CbGpPWpGaD
Etoposide—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	1.23e-05	0.000804	CbGpPWpGaD
Etoposide—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	1.22e-05	0.000795	CbGpPWpGaD
Etoposide—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	1.22e-05	0.000794	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.22e-05	0.000792	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	1.21e-05	0.000787	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—NDUFA12—bone cancer	1.21e-05	0.000787	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	1.18e-05	0.00077	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—NT5C3A—bone cancer	1.18e-05	0.000769	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—JUN—bone cancer	1.17e-05	0.00076	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—NDUFA12—bone cancer	1.16e-05	0.000756	CbGpPWpGaD
Etoposide—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	1.15e-05	0.000748	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—NT5C3A—bone cancer	1.14e-05	0.000741	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—RB1—bone cancer	1.12e-05	0.00073	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	1.11e-05	0.000721	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—BRCA2—bone cancer	1.1e-05	0.000717	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	1.1e-05	0.000717	CbGpPWpGaD
Etoposide—CYP2C8—Biological oxidations—GSTP1—bone cancer	1.07e-05	0.000697	CbGpPWpGaD
Etoposide—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	1.05e-05	0.000687	CbGpPWpGaD
Etoposide—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	1.04e-05	0.000675	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—ENO2—bone cancer	1.03e-05	0.000671	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	1e-05	0.000653	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—NT5C3A—bone cancer	1e-05	0.000652	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	9.98e-06	0.00065	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	9.88e-06	0.000644	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—NT5C3A—bone cancer	9.61e-06	0.000627	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	9.56e-06	0.000623	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—DHFR—bone cancer	9.55e-06	0.000622	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	9.36e-06	0.00061	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—NDUFA12—bone cancer	9.21e-06	0.0006	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CDK4—bone cancer	9.13e-06	0.000595	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—GNA11—bone cancer	8.92e-06	0.000581	CbGpPWpGaD
Etoposide—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.86e-06	0.000577	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—TP53—bone cancer	8.85e-06	0.000577	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	8.76e-06	0.000571	CbGpPWpGaD
Etoposide—CYP1A2—Biological oxidations—CYP3A4—bone cancer	8.7e-06	0.000567	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—NDUFA12—bone cancer	8.67e-06	0.000565	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—NDUFA12—bone cancer	8.65e-06	0.000564	CbGpPWpGaD
Etoposide—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	8.58e-06	0.000559	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	8.37e-06	0.000546	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.35e-06	0.000544	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CDK4—bone cancer	8.16e-06	0.000532	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—CYP3A4—bone cancer	8.09e-06	0.000527	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—MMP9—bone cancer	8.07e-06	0.000526	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	8.02e-06	0.000523	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—RB1—bone cancer	7.94e-06	0.000517	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	7.85e-06	0.000511	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	7.85e-06	0.000511	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—TP53—bone cancer	7.7e-06	0.000502	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—NT5C3A—bone cancer	7.63e-06	0.000497	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—NDUFA12—bone cancer	7.5e-06	0.000488	CbGpPWpGaD
Etoposide—CYP1A2—Biological oxidations—GSTP1—bone cancer	7.44e-06	0.000485	CbGpPWpGaD
Etoposide—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	7.34e-06	0.000478	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.21e-06	0.00047	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—NT5C3A—bone cancer	7.19e-06	0.000468	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—NT5C3A—bone cancer	7.17e-06	0.000467	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—RB1—bone cancer	7.1e-06	0.000463	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PTGS2—bone cancer	6.54e-06	0.000426	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NDUFA12—bone cancer	6.53e-06	0.000426	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—EGFR—bone cancer	6.52e-06	0.000425	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	6.5e-06	0.000423	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—ENO2—bone cancer	6.36e-06	0.000414	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	6.21e-06	0.000405	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—NT5C3A—bone cancer	6.21e-06	0.000405	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—MDM2—bone cancer	6.05e-06	0.000394	CbGpPWpGaD
Etoposide—ABCC1—Disease—ENO2—bone cancer	5.95e-06	0.000388	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—DHFR—bone cancer	5.9e-06	0.000384	CbGpPWpGaD
Etoposide—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.74e-06	0.000374	CbGpPWpGaD
Etoposide—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.66e-06	0.000369	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	5.65e-06	0.000368	CbGpPWpGaD
Etoposide—ABCC1—Disease—DHFR—bone cancer	5.52e-06	0.00036	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GNA11—bone cancer	5.51e-06	0.000359	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TP53—bone cancer	5.48e-06	0.000357	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NT5C3A—bone cancer	5.41e-06	0.000353	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NDUFA12—bone cancer	5.21e-06	0.00034	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ENO2—bone cancer	5.17e-06	0.000337	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—CYP3A4—bone cancer	5e-06	0.000326	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ENO2—bone cancer	4.98e-06	0.000325	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.97e-06	0.000324	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—DHFR—bone cancer	4.79e-06	0.000312	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—DHFR—bone cancer	4.62e-06	0.000301	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.6e-06	0.0003	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GNA11—bone cancer	4.48e-06	0.000292	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.44e-06	0.000289	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	4.44e-06	0.000289	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ENO2—bone cancer	4.38e-06	0.000286	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GNA11—bone cancer	4.32e-06	0.000281	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NT5C3A—bone cancer	4.32e-06	0.000281	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GSTP1—bone cancer	4.27e-06	0.000279	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ENO2—bone cancer	4.21e-06	0.000274	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—DHFR—bone cancer	4.07e-06	0.000265	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CYP3A4—bone cancer	4.06e-06	0.000265	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NDUFA12—bone cancer	4.02e-06	0.000262	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4e-06	0.000261	CbGpPWpGaD
Etoposide—ABCC1—Disease—TGFBR2—bone cancer	4e-06	0.000261	CbGpPWpGaD
Etoposide—PTGS2—Disease—ENO2—bone cancer	3.99e-06	0.00026	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CYP3A4—bone cancer	3.92e-06	0.000255	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—DHFR—bone cancer	3.91e-06	0.000255	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.9e-06	0.000254	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GNA11—bone cancer	3.8e-06	0.000248	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.73e-06	0.000243	CbGpPWpGaD
Etoposide—PTGS2—Disease—DHFR—bone cancer	3.7e-06	0.000241	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GNA11—bone cancer	3.65e-06	0.000238	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PTGS2—bone cancer	3.58e-06	0.000234	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GSTP1—bone cancer	3.47e-06	0.000226	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TP53—bone cancer	3.47e-06	0.000226	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CYP3A4—bone cancer	3.45e-06	0.000225	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GSTP1—bone cancer	3.35e-06	0.000218	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ENO2—bone cancer	3.34e-06	0.000218	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NT5C3A—bone cancer	3.33e-06	0.000217	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CYP3A4—bone cancer	3.31e-06	0.000216	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.29e-06	0.000215	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ENO2—bone cancer	3.15e-06	0.000205	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.15e-06	0.000205	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ENO2—bone cancer	3.14e-06	0.000205	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—DHFR—bone cancer	3.1e-06	0.000202	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GSTP1—bone cancer	2.95e-06	0.000192	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—DHFR—bone cancer	2.92e-06	0.00019	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—DHFR—bone cancer	2.91e-06	0.00019	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GNA11—bone cancer	2.9e-06	0.000189	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GSTP1—bone cancer	2.83e-06	0.000185	CbGpPWpGaD
Etoposide—ABCC1—Disease—KIT—bone cancer	2.73e-06	0.000178	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GNA11—bone cancer	2.73e-06	0.000178	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GNA11—bone cancer	2.72e-06	0.000177	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ENO2—bone cancer	2.72e-06	0.000177	CbGpPWpGaD
Etoposide—PTGS2—Disease—TGFBR2—bone cancer	2.68e-06	0.000175	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.64e-06	0.000172	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP3A4—bone cancer	2.63e-06	0.000171	CbGpPWpGaD
Etoposide—ABCC1—Disease—BRAF—bone cancer	2.56e-06	0.000167	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—DHFR—bone cancer	2.52e-06	0.000164	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP3A4—bone cancer	2.47e-06	0.000161	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP3A4—bone cancer	2.47e-06	0.000161	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ENO2—bone cancer	2.37e-06	0.000154	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GNA11—bone cancer	2.36e-06	0.000154	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GSTP1—bone cancer	2.25e-06	0.000146	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTGS2—bone cancer	2.21e-06	0.000144	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—DHFR—bone cancer	2.2e-06	0.000143	CbGpPWpGaD
Etoposide—ABCC1—Disease—MDM2—bone cancer	2.15e-06	0.00014	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP3A4—bone cancer	2.14e-06	0.000139	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.13e-06	0.000139	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSTP1—bone cancer	2.12e-06	0.000138	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSTP1—bone cancer	2.11e-06	0.000138	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTGS2—bone cancer	2.07e-06	0.000135	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GNA11—bone cancer	2.05e-06	0.000134	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ENO2—bone cancer	1.89e-06	0.000123	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP3A4—bone cancer	1.86e-06	0.000121	CbGpPWpGaD
Etoposide—PTGS2—Disease—KIT—bone cancer	1.83e-06	0.000119	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTP1—bone cancer	1.83e-06	0.000119	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTGS2—bone cancer	1.8e-06	0.000117	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—DHFR—bone cancer	1.76e-06	0.000114	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTGS2—bone cancer	1.74e-06	0.000113	CbGpPWpGaD
Etoposide—PTGS2—Disease—BRAF—bone cancer	1.72e-06	0.000112	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GNA11—bone cancer	1.64e-06	0.000107	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTP1—bone cancer	1.59e-06	0.000104	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTGS2—bone cancer	1.53e-06	9.95e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP3A4—bone cancer	1.49e-06	9.69e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.48e-06	9.64e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—EGFR—bone cancer	1.47e-06	9.57e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTGS2—bone cancer	1.47e-06	9.56e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ENO2—bone cancer	1.46e-06	9.52e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MDM2—bone cancer	1.44e-06	9.4e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—DHFR—bone cancer	1.35e-06	8.83e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTP1—bone cancer	1.27e-06	8.29e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GNA11—bone cancer	1.27e-06	8.25e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTGS2—bone cancer	1.1e-06	7.14e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTGS2—bone cancer	1.09e-06	7.13e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—EGFR—bone cancer	9.86e-07	6.42e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTP1—bone cancer	9.82e-07	6.4e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTGS2—bone cancer	9.47e-07	6.17e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTGS2—bone cancer	8.25e-07	5.38e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS2—bone cancer	6.59e-07	4.29e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS2—bone cancer	5.09e-07	3.31e-05	CbGpPWpGaD
